Lipocine Inc (NASDAQ: LPCN) stock enjoyed a major increase of 13.9% on 3/26/24. The shares closed at $5.01. Moreover, trading volume in this advance was exceptionally high at 223% of normal. The stock has risen 11.6% during the last week but has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
With future capital returns forecasted to be below the cost of capital, LPCN is expected to continue to be a modest Value Eraser.
Lipocine has a current Value Trend Rating of D (Negative). The Value Trend Rating reflects inconsistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Lipocine has a neutral Appreciation Score of 55 but a poor Power Rating of 30, and the Negative Value Trend Rating results.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment